{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T14:12:07Z","timestamp":1779804727629,"version":"3.53.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Klin Intensivmed Notfmed"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00063-026-01439-0","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T05:59:09Z","timestamp":1776146349000},"page":"404-415","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Management von Notf\u00e4llen in der Rheumatologie","Management of emergencies in rheumatology"],"prefix":"10.1007","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7829-5574","authenticated-orcid":false,"given":"Philine","family":"Ritter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan M.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"key":"1439_CR1","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41572-021-00327-5","volume":"7","author":"D Pugh","year":"2022","unstructured":"Pugh\u00a0D, Karabayas\u00a0M, Basu\u00a0N et\u00a0al (2022) Large-vessel vasculitis. Nat Rev Dis Primers 7:93\u201393. https:\/\/doi.org\/10.1038\/s41572-021-00327-5","journal-title":"Nat Rev Dis Primers"},{"key":"1439_CR2","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1136\/ard-2022-223480","volume":"81","author":"C Ponte","year":"2022","unstructured":"Ponte\u00a0C, Grayson\u00a0PC, Robson\u00a0JC et\u00a0al (2022) 2022 American College of Rheumatology\/EULAR classification criteria for giant cell arteritis. Ann Rheum Dis 81:1647\u20131653. https:\/\/doi.org\/10.1136\/ard-2022-223480","journal-title":"Ann Rheum Dis"},{"key":"1439_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/annrheumdis-2019-215672","volume":"79","author":"B Hellmich","year":"2020","unstructured":"Hellmich\u00a0B, Agueda\u00a0A, Monti\u00a0S et\u00a0al (2020) 2018 Update of the EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 79:19\u201330. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215672","journal-title":"Ann Rheum Dis"},{"key":"1439_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.reuma.2015.02.003","volume":"12","author":"JM Ornelas-Aguirre","year":"2016","unstructured":"Ornelas-Aguirre\u00a0JM (2016) Septic arthritis in adults in a tertiary care center. Reumatol Clin 12:27\u201333. https:\/\/doi.org\/10.1016\/j.reuma.2015.02.003","journal-title":"Reumatol Clin"},{"key":"1439_CR5","doi-asserted-by":"publisher","first-page":"331","DOI":"10.5811\/westjem.2018.10.40974","volume":"20","author":"B Long","year":"2019","unstructured":"Long\u00a0B, Koyfman\u00a0A, Gottlieb\u00a0M (2019) Evaluation and Management of Septic Arthritis and its Mimics in the Emergency Department. West J Emerg Med 20:331\u2013341. https:\/\/doi.org\/10.5811\/westjem.2018.10.40974","journal-title":"West J Emerg Med"},{"key":"1439_CR6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.65883","volume":"16","author":"AD Kaye","year":"2024","unstructured":"Kaye\u00a0AD, Greene\u00a0D, Alvarez-Amado\u00a0AV et\u00a0al (2024) Pathophysiology and Evolving Treatment Options of Septic Arthritis: A Narrative Review. Cureus 16:e65883. https:\/\/doi.org\/10.7759\/cureus.65883","journal-title":"Cureus"},{"key":"1439_CR7","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1210\/clinem\/dgac151","volume":"107","author":"SW Borresen","year":"2022","unstructured":"Borresen\u00a0SW, Klose\u00a0M, Glintborg\u00a0D et\u00a0al (2022) Approach to the Patient With Glucocorticoid-induced Adrenal Insufficiency. J\u00a0Clin Endocrinol Metab 107:2065\u20132076. https:\/\/doi.org\/10.1210\/clinem\/dgac151","journal-title":"J Clin Endocrinol Metab"},{"key":"1439_CR8","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/anae.14963","volume":"75","author":"T Woodcock","year":"2020","unstructured":"Woodcock\u00a0T, Barker\u00a0P, Daniel\u00a0S et\u00a0al (2020) Guidelines for the management of glucocorticoids during the peri-operative period for patients with adrenal insufficiency: Guidelines from the Association of Anaesthetists, the Royal College of Physicians and the Society for Endocrinology UK. Anaesthesia 75:654\u2013663. https:\/\/doi.org\/10.1111\/anae.14963","journal-title":"Anaesthesia"},{"key":"1439_CR9","doi-asserted-by":"publisher","DOI":"10.1177\/2042018819848218","volume":"10","author":"R Dineen","year":"2019","unstructured":"Dineen\u00a0R, Thompson\u00a0CJ, Sherlock\u00a0M (2019) Adrenal crisis: prevention and management in adult patients. Ther Adv Endocrinol Metab 10:2042018819848218. https:\/\/doi.org\/10.1177\/2042018819848218","journal-title":"Ther Adv Endocrinol Metab"},{"key":"1439_CR10","doi-asserted-by":"publisher","first-page":"G25","DOI":"10.1093\/ejendo\/lvae029","volume":"190","author":"F Beuschlein","year":"2024","unstructured":"Beuschlein\u00a0F, Else\u00a0T, Bancos\u00a0I et\u00a0al (2024) European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and therapy of glucocorticoid-induced adrenal insufficiency. Eur J Endocrinol 190:G25\u2013G51. https:\/\/doi.org\/10.1093\/ejendo\/lvae029","journal-title":"Eur J Endocrinol"},{"key":"1439_CR11","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00035-19","author":"JS Davis","year":"2020","unstructured":"Davis\u00a0JS, Ferreira\u00a0D, Paige\u00a0E et\u00a0al (2020) Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies. Clin Microbiol Rev. https:\/\/doi.org\/10.1128\/cmr.00035-19","journal-title":"Clin Microbiol Rev"},{"key":"1439_CR12","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00296-022-05270-6","volume":"43","author":"CG Gialouri","year":"2023","unstructured":"Gialouri\u00a0CG, Moustafa\u00a0S, Thomas\u00a0K et\u00a0al (2023) Herpes zoster in patients with inflammatory arthritides or ulcerative colitis treated with tofacitinib, baricitinib or upadacitinib: a systematic review of clinical trials and real-world studies. Rheumatol Int 43:421\u2013435. https:\/\/doi.org\/10.1007\/s00296-022-05270-6","journal-title":"Rheumatol Int"},{"key":"1439_CR13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.74183","volume":"16","author":"T Mamiya","year":"2024","unstructured":"Mamiya\u00a0T, Kobayashi\u00a0H, Takeuchi\u00a0S et\u00a0al (2024) Severe Varicella-Zoster Virus Pneumonia in an Unvaccinated Patient With Rheumatoid Arthritis: A Case Report and Literature Review. Cureus 16:e74183. https:\/\/doi.org\/10.7759\/cureus.74183","journal-title":"Cureus"},{"key":"1439_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11226714","author":"JI Shin","year":"2022","unstructured":"Shin\u00a0JI, Lee\u00a0KH, Park\u00a0S et\u00a0al (2022) Systemic Lupus Erythematosus and Lung Involvement: A Comprehensive Review. J\u00a0Clin Med. https:\/\/doi.org\/10.3390\/jcm11226714","journal-title":"J Clin Med"},{"key":"1439_CR15","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.reuma.2018.03.012","volume":"14","author":"G Aguilera-Pickens","year":"2018","unstructured":"Aguilera-Pickens\u00a0G, Abud-Mendoza\u00a0C (2018) Pulmonary manifestations in systemic lupus erythematosus: pleural involvement, acute pneumonitis, chronic interstitial lung disease and diffuse alveolar hemorrhage. Reumatol Clin (Engl Ed) 14:294\u2013300. https:\/\/doi.org\/10.1016\/j.reuma.2018.03.012","journal-title":"Reumatol Clin (Engl Ed)"},{"key":"1439_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/ard-2023-224762","volume":"83","author":"A Fanouriakis","year":"2024","unstructured":"Fanouriakis\u00a0A, Kostopoulou\u00a0M, Andersen\u00a0J et\u00a0al (2024) EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis 83:15\u201329. https:\/\/doi.org\/10.1136\/ard-2023-224762","journal-title":"Ann Rheum Dis"},{"key":"1439_CR17","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1164\/rccm.202308-1426OC","volume":"209","author":"LA Fussner","year":"2024","unstructured":"Fussner\u00a0LA, Flores-Su\u00e1rez\u00a0LF, Cartin-Ceba\u00a0R et\u00a0al (2024) Alveolar Hemorrhage in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Results of an International Randomized Controlled Trial (PEXIVAS). Am J Respir Crit Care Med 209:1141\u20131151. https:\/\/doi.org\/10.1164\/rccm.202308-1426OC","journal-title":"Am J Respir Crit Care Med"},{"key":"1439_CR18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1136\/ard-2022-223764","volume":"83","author":"B Hellmich","year":"2024","unstructured":"Hellmich\u00a0B, Sanchez-Alamo\u00a0B, Schirmer\u00a0JH et\u00a0al (2024) EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update. Ann Rheum Dis 83:30\u201347. https:\/\/doi.org\/10.1136\/ard-2022-223764","journal-title":"Ann Rheum Dis"},{"key":"1439_CR19","unstructured":"Intensivmedizin DGfAu (2017) S3-Leitlinie Invasive Beatmung und Einsatz extrakorporaler Verfahren bei akuter respiratorischer Insuffizienz."},{"key":"1439_CR20","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02776-2021","author":"P Spagnolo","year":"2022","unstructured":"Spagnolo\u00a0P, Bonniaud\u00a0P, Rossi\u00a0G et\u00a0al (2022) Drug-induced interstitial lung disease. Eur Respir\u00a0J. https:\/\/doi.org\/10.1183\/13993003.02776-2021","journal-title":"Eur Respir J"},{"key":"1439_CR21","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1177\/10600280221134719","volume":"57","author":"J Summerlin","year":"2023","unstructured":"Summerlin\u00a0J, Wells\u00a0DA, Anderson\u00a0MK et\u00a0al (2023) A Review of Current and Emerging Therapeutic Options for Hemophagocytic Lymphohistiocytosis. Ann Pharmacother 57:867\u2013879. https:\/\/doi.org\/10.1177\/10600280221134719","journal-title":"Ann Pharmacother"},{"key":"1439_CR22","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1182\/blood.2018894618","volume":"133","author":"P La Ros\u00e9e","year":"2019","unstructured":"La Ros\u00e9e\u00a0P, Horne\u00a0A, Hines\u00a0M et\u00a0al (2019) Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood 133:2465\u20132477. https:\/\/doi.org\/10.1182\/blood.2018894618","journal-title":"Blood"},{"key":"1439_CR23","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1111\/apa.15973","volume":"110","author":"S Imashuku","year":"2021","unstructured":"Imashuku\u00a0S, Morimoto\u00a0A, Ishii\u00a0E (2021) Virus-triggered secondary hemophagocytic lymphohistiocytosis. Acta Paediatr 110:2729\u20132736. https:\/\/doi.org\/10.1111\/apa.15973","journal-title":"Acta Paediatr"},{"key":"1439_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25010668","author":"V Bitsadze","year":"2024","unstructured":"Bitsadze\u00a0V, Yakubova\u00a0F, Khizroeva\u00a0J et\u00a0al (2024) Catastrophic Antiphospholipid Syndrome. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25010668","journal-title":"Int J Mol Sci"},{"key":"1439_CR25","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/bor.0000000000000932","volume":"35","author":"A Ambati","year":"2023","unstructured":"Ambati\u00a0A, Knight\u00a0JS, Zuo\u00a0Y (2023) Antiphospholipid syndrome management: a 2023 update and practical algorithm-based approach. Curr Opin Rheumatol 35:149\u2013160. https:\/\/doi.org\/10.1097\/bor.0000000000000932","journal-title":"Curr Opin Rheumatol"},{"key":"1439_CR26","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1002\/art.42624","volume":"75","author":"M Barbhaiya","year":"2023","unstructured":"Barbhaiya\u00a0M, Zuily\u00a0S, Naden\u00a0R et\u00a0al (2023) The 2023 ACR\/EULAR Antiphospholipid Syndrome Classification Criteria. Arthritis Rheumatol 75:1687\u20131702. https:\/\/doi.org\/10.1002\/art.42624","journal-title":"Arthritis Rheumatol"},{"key":"1439_CR27","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1136\/annrheumdis-2019-215213","volume":"78","author":"MG Tektonidou","year":"2019","unstructured":"Tektonidou\u00a0MG, Andreoli\u00a0L, Limper\u00a0M et\u00a0al (2019) EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis 78:1296\u20131304. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215213","journal-title":"Ann Rheum Dis"},{"key":"1439_CR28","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1191\/0961203303lu394oa","volume":"12","author":"RA Asherson","year":"2003","unstructured":"Asherson\u00a0RA, Cervera\u00a0R, de Groot\u00a0PG et\u00a0al (2003) Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus 12:530\u2013534. https:\/\/doi.org\/10.1191\/0961203303lu394oa","journal-title":"Lupus"},{"key":"1439_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/msc.1859","volume":"22","author":"G Alp","year":"2024","unstructured":"Alp\u00a0G, Cinakli\u00a0H, Akar\u00a0S et\u00a0al (2024) Prevalence of anterior atlantoaxial subluxation and association with established rheumatoid arthritis. Musculoskeletal Care 22:e1859. https:\/\/doi.org\/10.1002\/msc.1859","journal-title":"Musculoskeletal Care"},{"key":"1439_CR30","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1136\/annrheumdis-2012-203158","volume":"72","author":"AN Colebatch","year":"2013","unstructured":"Colebatch\u00a0AN, Edwards\u00a0CJ, \u00d8stergaard\u00a0M et\u00a0al (2013) EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis. Ann Rheum Dis 72:804\u2013814. https:\/\/doi.org\/10.1136\/annrheumdis-2012-203158","journal-title":"Ann Rheum Dis"},{"key":"1439_CR31","doi-asserted-by":"publisher","first-page":"67","DOI":"10.14740\/jocmr6149","volume":"17","author":"D Patschan","year":"2025","unstructured":"Patschan\u00a0D, Schmalz\u00a0G, Safi\u00a0W et\u00a0al (2025) Acute Kidney Injury in Autoimmune-Mediated Rheumatic Diseases. J\u00a0Clin Med Res 17:67\u201375. https:\/\/doi.org\/10.14740\/jocmr6149","journal-title":"J Clin Med Res"},{"key":"1439_CR32","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s00132-019-03807-5","volume":"48","author":"SM Weiner","year":"2019","unstructured":"Weiner\u00a0SM (2019) Treatment of rheumatic disease with renal insufficiency. Orthopade 48:927\u2013935. https:\/\/doi.org\/10.1007\/s00132-019-03807-5","journal-title":"Orthopade"},{"key":"1439_CR33","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s00108-019-0575-x","volume":"60","author":"M Haubitz","year":"2019","unstructured":"Haubitz\u00a0M (2019) Rapid progressive glomerulonephritis. Internist (Berl) 60:478\u2013484. https:\/\/doi.org\/10.1007\/s00108-019-0575-x","journal-title":"Internist (Berl)"},{"key":"1439_CR34","unstructured":"DGRh (2025) S2k-Leitlinie Diagnostik und Therapie der systemischen Sklerosen. https:\/\/register.awmf.org\/de\/leitlinien\/detail\/060-014. Accessed 21.8.2025"},{"key":"1439_CR35","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1016\/j.ekir.2024.06.031","volume":"9","author":"M Sallee","year":"2024","unstructured":"Sallee\u00a0M, Resseguier\u00a0N, Crepin\u00a0T et\u00a0al (2024) Immunoadsorption and Plasma Exchange are Comparable in Anti-Neutrophil Cytoplasmic Antibodies or Anti-Glomerular Basement Membrane Removal Kinetics. Kidney Int Rep 9:2767\u20132773. https:\/\/doi.org\/10.1016\/j.ekir.2024.06.031","journal-title":"Kidney Int Rep"},{"key":"1439_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.572863","volume":"11","author":"GE Fouda","year":"2020","unstructured":"Fouda\u00a0GE, Bavbek\u00a0S (2020) Rituximab Hypersensitivity: From Clinical Presentation to Management. Front Pharmacol 11:572863. https:\/\/doi.org\/10.3389\/fphar.2020.572863","journal-title":"Front Pharmacol"},{"key":"1439_CR37","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.semarthrit.2015.06.014","volume":"45","author":"P Karmacharya","year":"2015","unstructured":"Karmacharya\u00a0P, Poudel\u00a0DR, Pathak\u00a0R et\u00a0al (2015) Rituximab-induced serum sickness: A systematic review. Semin Arthritis Rheum 45:334\u2013340. https:\/\/doi.org\/10.1016\/j.semarthrit.2015.06.014","journal-title":"Semin Arthritis Rheum"},{"key":"1439_CR38","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1136\/annrheumdis-2021-220578","volume":"81","author":"VE Saper","year":"2022","unstructured":"Saper\u00a0VE, Ombrello\u00a0MJ, Tremoulet\u00a0AH et\u00a0al (2022) Severe delayed hypersensitivity reactions to IL\u20111 and IL\u20116 inhibitors link to common HLA-DRB1*15 alleles. Ann Rheum Dis 81:406\u2013415. https:\/\/doi.org\/10.1136\/annrheumdis-2021-220578","journal-title":"Ann Rheum Dis"},{"key":"1439_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2022.100673","volume":"16","author":"AM Calle","year":"2023","unstructured":"Calle\u00a0AM, Aguirre\u00a0N, Ardila\u00a0JC et\u00a0al (2023) DRESS syndrome: A literature review and treatment algorithm. World Allergy Organ\u00a0J 16:100673. https:\/\/doi.org\/10.1016\/j.waojou.2022.100673","journal-title":"World Allergy Organ J"}],"container-title":["Medizinische Klinik - Intensivmedizin und Notfallmedizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-026-01439-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00063-026-01439-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-026-01439-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T13:38:31Z","timestamp":1779802711000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00063-026-01439-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1439"],"URL":"https:\/\/doi.org\/10.1007\/s00063-026-01439-0","relation":{},"ISSN":["2193-6218","2193-6226"],"issn-type":[{"value":"2193-6218","type":"print"},{"value":"2193-6226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"assertion":[{"value":"8 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autorinnen und Autoren sowie die Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"P.\u00a0Ritter\n                      : A.\u00a0Finanzielle Interessen:\n                      P.\u00a0Ritter\n                      gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: \u00c4rztin in Weiterbildung f\u00fcr Innere Medizin, Centre Hospitalier Emile Mayrisch, Esch-sur-Alzette, Luxemburg.\n                      S.M.\u00a0Weiner\n                      : A.\u00a0Finanzielle Interessen: Referentenhonorare bei industrieorganisierten Symposien von Abbvie, Astra-Zeneca, Bayer-Vital, Boehringer Ingelheim, CSL Vifor, Novartis, Otsuka. Referentenhonorare bei industriegesponsorten Fortbildungsveranstaltung (Streamed up, Rheuma Update, D\u00fcsseldorfer Nieren- und Hochdrucktage, Arbeitskreis Nephrologie Saar-Pfalz-Mosel, P\u00fcttlinger Rheumasymposium). | Kostenerstattung (Reise- und \u00dcbernachtungskosten sowie Teilnahmegeb\u00fchr) f\u00fcr Teilnahme an folgenden Kongressen: EULAR 2022\u20132025 (UCB), DGfN 2022 und 2025 (Alexion), 2023 (Boehringer Ingelheim), ESID 2022 und 2024 (CSL Behring), DGRh 2021 (Pfizer), 2022 und 2023 (Boehringer Ingelheim), 2024 (Abbvie), 2025 (Johnson & Johnson).\u00a0\u2013 Honorar f\u00fcr Teilnahme an Advisory Board der Firma Novartis zum Thema Riesenzellarteriitis und Firma Abbvie zum Thema Riesenzellarteriitis und rheumatoide Arthritis.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Chefarzt 2.\u00a0Medizinische Abteilung, Krankenhaus der Barmherzigen Br\u00fcder Trier; leitender Arzt KfH Nierenzentrum Nordallee Trier | 1.\u00a0Vorstandsvorsitzender des Arbeitskreises Nephrologie Saar-Pfalz-Mosel e.\u202fV.; Schatzmeister der Saarl\u00e4ndisch-Pf\u00e4lzischen Internistengesellschaft e.\u202fV.; Mitglied des erweiterten Vorstands der Deutschen Gesellschaft f\u00fcr Nephrologie | Mitgliedschaften: Deutsche Gesellschaft f\u00fcr Rheumatologie, Deutsche Gesellschaft f\u00fcr Innere Medizin, Deutsche Gesellschaft f\u00fcr Immunologie, Arbeitsgemeinschaft Rheumatologie Rheinland-Pfalz.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autorinnen und Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf\n                      \n                      .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}